2009
DOI: 10.1016/j.jbiotec.2008.12.013
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of RegA, a pathway-specific regulator of the friulimicin biosynthesis in Actinoplanes friuliensis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 34 publications
0
6
0
Order By: Relevance
“…This correlates with the onset of friulimicin production (Nolden et al, 2009). The analysis of pstA under the control of the ermE* promoter showed no significant differences in the transcription rate during the cultivation.…”
Section: Comparison Of Heterologous and Homologous Promoter Strengthsmentioning
confidence: 68%
See 2 more Smart Citations
“…This correlates with the onset of friulimicin production (Nolden et al, 2009). The analysis of pstA under the control of the ermE* promoter showed no significant differences in the transcription rate during the cultivation.…”
Section: Comparison Of Heterologous and Homologous Promoter Strengthsmentioning
confidence: 68%
“…To characterize the function of friulimicin biosynthetic genes by gene inactivation, the aprP-resistance cassette was used for the generation of gene replacement and gene insertion mutants of A. friuliensis (Heinzelmann et al, 2003;Müller et al, 2007;Nolden et al, 2009). For construction of this cassette, the ermE* promoter was selected in order to ensure transcription of genes downstream of the gene interruption site.…”
Section: Comparison Of Heterologous and Homologous Promoter Strengthsmentioning
confidence: 99%
See 1 more Smart Citation
“…Their corresponding counterparts RegA, RegB, RegC and RegD were identified in the friulimicin cluster (Muller et al, 2007). RegA was demonstrated as a pathway-specific regulator of friulimicin biosynthesis in Actinoplanes friuliensis (Nolden et al, 2009). Inactivation of RegA resulted in abolishment of friulimicin production in the mutant.…”
Section: Resultsmentioning
confidence: 99%
“…In contrast to LAL, RegA is a small protein (254 aa) with a helix-turn-helix motif of LuxR type at the C-terminal end. Deletion of regA results in friulimicin nonproducing mutants, indicating that RegA positively regulates friulimicin biosynthesis [Nolden et al, 2009]. Gene expression analysis shows that the expression of most of friumicin biosynthetic genes is impaired in the mutant, while the expression of regA is enhanced, indicating that RegA negatively controls its own expression.…”
Section: Pathway Specific Regulatory Genesmentioning
confidence: 99%